T-705 (Favipiravir) is an antiviral drug that selectively inhibitsthe RNA-dependent RNA polymerase of influenza virus. It isphosphoribosylated by cellular enzymes to its active form,favipiravir-ribofuranosyl-5"-triphosphate (RTP). Favipiravir isactive against a broad range of influenza viruses, includingA(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9)avian virus. It also inhibits influenza strains resistant to currentantiviral drugs, and shows a synergistic effect in combinationwith oseltamivir, thereby expanding influenza treatmentoptions. Recently, T-705 has been shown to give 100%protection against aerosol Ebola virus E718 infection inimmune-deficient mice as well as inhibiting Ebola virusinfection in cell culture. 用产品只提供给进一步的科研使用，不可应用于治疗等其他方面。 rPeptide是设在雅典，美国佐治亚州的一家生物技术公司，是一种在阿尔茨海默氏症和帕金森氏病的研究提供研究产品（重组多肽和蛋白质，抗体，试剂）市场的*。rPeptide还提供定制服务的范围从分子生物学，蛋白表达和纯化，13C和15N的多肽和蛋白质的统一标识。 rPeptide有一个专有的平台载体技术，使可溶性肽/蛋白在大肠杆菌中（如淀，β-淀粉样蛋白，瘦素，亲胰岛素）历史上的困难肽/蛋白表达。 商品名称    商品货号    商品品牌 Beta-Amyloid (1-40), Mouse, Rat    A-1007-1    rPeptide Beta-Amyloid (1-40), Starter Kit    A-1150-1    rPeptide Beta-Amyloid (1-40), Starter Kit    A-1150-2    rPeptide Beta-Amyloid (1-40), Ultra Pure, HCl    A-1156-1    rPeptide Beta-Amyloid (1-40), Ultra Pure, HCl    A-1156-2    rPeptide Beta-Amyloid (1-40), Ultra Pure, HFIP    A-1153-1    rPeptide Beta-Amyloid (1-40), Ultra Pure, HFIP    A-1153-2    rPeptide Beta-Amyloid (1-40), Ultra Pure, NaOH    A-1155-1    rPeptide Beta-Amyloid (1-40), Ultra Pure, NaOH    A-1155-2    rPeptide Beta-Amyloid (1-40), Ultra Pure, TFA    A-1001-1    rPeptide Beta-Amyloid (1-40), Ultra Pure, TFA    A-1001-2    rPeptide Beta-Amyloid (1-40, D23N)    A-1013-1    rPeptide Beta-Amyloid (1-40, D23N)    A-1013-2    rPeptide Beta-Amyloid (1-40, F4W)    A-1011-1    rPeptide Beta-Amyloid (1-40, F4W)    A-1011-2    rPeptide